Key result
Discharge to a skilled nursing facility for inpatient oncology patients was associated with a longer length of stay compared to discharge home under self-care.
Why the study?
Identifying additional clinical factors affecting length of stay and readmissions was needed to guide further oncology hospitalist practice improvement.
Does discharge to a skilled nursing facility affect length of stay and readmission rates in inpatient oncology patients?
Cohort (n=1,236)
Does discharge to a skilled nursing facility affect length of stay and readmission rates in inpatient oncology patients?
Discharge to a skilled nursing facility for inpatient oncology patients is associated with longer length of stay and high readmission rates, highlighting the need for upfront discharge planning.
Answers are grounded in this paper and cite their sources.
SNF discharge was associated with higher readmissions; leaves open whether targeted planning improves oncology outcomes.
BACKGROUND: Hospitalist comanagement of inpatient oncology patients can improve length of stay (LOS), discharge time, and readmission rates. Identifying additional clinical factors affecting LOS and readmissions will guide further oncology hospitalist practice improvement. METHODS: Hospitalizations on the Smilow Cancer Hospital medical oncology service with discharge to home under self-care (n = 622), home with services (n = 462), or skilled nursing facility (n = 152) from July 1, 2021, to July 31, 2022, were included. Outcomes included LOS, time of discharge, and 30-day readmission rate. Multivariable mixed linear (LOS, time of discharge) or Poisson (30-day readmission rates) models were adjusted for demographics, cancer type, severity of illness index, house staff team, and fiscal quarter and included a random intercept for patient. Analyses were 2-sided with a priori statistical significance of less than 0.05. RESULTS: Patients discharged to a skilled nursing facility had a longer LOS (mean = 8.25 days, 95% confidence interval [CI] = 7.13 to 9.55 days) compared with patients discharged to home under self-care (mean = 3.04 days, 95% CI = 2.76 to 3.36 days) or with services (mean = 4.48 days, 95% CI = 4.03 to 4.97 days; P < .0001). Thirty-day readmission rates for patients discharged to a skilled nursing facility (43.99%) were 10 percentage points higher than those discharged home either under self-care (32.86%) or with services (33.48%; P = .14). These differences persisted in patients regardless of severity of illness index. Of the 152 patients discharged to a skilled nursing facility, 31 (20.3%) were readmitted specifically back to the medical oncology service within 60 days with 16 (51.6%) cycling back to a skilled nursing facility, which resulted in 11 second readmissions. CONCLUSION: For oncology patients requiring discharge to a skilled nursing facility, mindful and upfront discharge planning may improve care quality and efficiency.
No takes yet. Share an insight, caveat, or question.
Rothberg et al. (2025) conducted a cohort in Inpatient oncology (n=1,236). Discharge to a skilled nursing facility vs. Discharge to home under self-care or home with services was evaluated on Length of stay (p=<.0001). Discharge to a skilled nursing facility for inpatient oncology patients was associated with a longer length of stay compared to discharge home under self-care.
Synapse has enriched 10 related papers. Consider them for comparative context: